TRIP15 Activators encompass a range of chemical compounds that indirectly augment the functional activity of TRIP15, primarily through modulation of various signaling pathways and cellular processes. Forskolin, by increasing cAMP levels and activating PKA, indirectly influences ubiquitination processes where TRIP15 is involved, enhancing its functional activity in protein regulation. Rapamycin, as an mTOR inhibitor, and LY294002, a PI3K inhibitor, both alter cellular metabolic responses and AKT signaling, respectively. These alterations can indirectly enhance TRIP15's role in protein ubiquitination and degradation. Similarly, U0126 and SB203580, inhibitors of MEK1/2 and p38 MAPK, respectively, shift cellular signaling in a way that could enhance TRIP15's activity in ubiquitin-mediated processes. Wortmannin, another PI3K inhibitor, and Thapsigargin, which elevates intracellular calcium levels, both have potential to augment TRIP15's function by affecting interconnected signaling pathways related to protein stability and degradation.
Staurosporine, a broad-spectrum kinase inhibitor, and Epigallocatechin gallate, also a kinase inhibitor, influence various cellular signaling pathways, potentially enhancing TRIP15's role in ubiquitination processes. Sphingosine-1-phosphate, involved in lipid signaling, can indirectly affect TRIP15's functional activity by altering protein regulation mechanisms. A23187, by increasing calcium levels, activates calcium-dependent pathways that intersect with ubiquitin-proteasome systems, potentially enhancing TRIP15's involvement in these processes. Bortezomib, a proteasome inhibitor, can indirectly enhance TRIP15's activity within the ubiquitin ligase complex by altering protein turnover dynamics. Collectively, these TRIP15 Activators, through their targeted effects on cellular signaling and protein regulation pathways, facilitate the enhancement of TRIP15-mediated functions, particularly in ubiquitin-mediated protein regulation, without the need for upregulating its expression or direct activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, increasing cAMP levels and activating PKA. This can indirectly enhance TRIP15's activity in the ubiquitin ligase complex. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that shifts cellular metabolic and growth responses, potentially enhancing TRIP15's role in protein regulation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor disrupting AKT signaling, potentially enhancing TRIP15's role in ubiquitin-mediated regulation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that can influence stress responses and protein stability, potentially affecting TRIP15's activity in the ubiquitination pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A potent PI3K inhibitor, altering AKT pathway signaling and potentially enhancing TRIP15's functional role in ubiquitin-mediated protein regulation. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Raises intracellular calcium levels, potentially activating pathways that enhance TRIP15's activity in ubiquitin ligase complexes. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A broad-spectrum protein kinase inhibitor that can indirectly affect ubiquitination processes involving TRIP15. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Involved in lipid signaling and can affect cellular processes related to protein stability and degradation, potentially enhancing TRIP15's functional activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
A kinase inhibitor that might indirectly affect the ubiquitin-mediated processes where TRIP15 is involved, enhancing its functional activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
An ionophore increasing intracellular calcium levels, activating pathways that intersect with the ubiquitin-proteasome system, potentially enhancing TRIP15's role. | ||||||